Close Menu

NEW YORK – The National Cancer Institute said on Thursday it has launched the Serological Sciences Network for COVID-19 (SeroNet) to increase serological testing capacity in the US and better understand the immune response to the coronavirus.

More than 25 academic, government, and private sector research institutions will be part of the network, which also aims to accelerate the development of treatments and vaccines for the disease.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.